000 01481 a2200349 4500
005 20250518043212.0
264 0 _c20200610
008 202006s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.18.01418
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKilbride, Madison K
245 0 0 _aHow Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests?
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_c10 2019
300 _a2514-2517 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aBreast Neoplasms
_xprevention & control
650 0 4 _aDirect-To-Consumer Screening and Testing
_xmethods
650 0 4 _aFemale
650 0 4 _aHealth Personnel
_xpsychology
650 0 4 _aHumans
650 0 4 _aLanguage
650 0 4 _aPatients
_xpsychology
650 0 4 _aProphylactic Mastectomy
_xmethods
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
_xstandards
700 1 _aDomchek, Susan M
700 1 _aBradbury, Angela R
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 37
_gno. 28
_gp. 2514-2517
856 4 0 _uhttps://doi.org/10.1200/JCO.18.01418
_zAvailable from publisher's website
999 _c29773410
_d29773410